Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613.HK) revealed earnings for full year that Dropped, from the same period last year
The company's bottom line came in at HK$397.21 million, or HK$0.47 per share. This compares with HK$500.27 million, or HK$0.60 per share, last year.
The company's revenue for the period fell 6.2% to HK$1.51 billion from HK$1.61 billion last year.
Beijing Tong Ren Tang Chinese Medicine Co Ltd earnings at a glance (GAAP) :
-Earnings: HK$397.21 Mln. vs. HK$500.27 Mln. last year.-EPS: HK$0.47 vs. HK$0.60 last year.-Revenue: HK$1.51 Bln vs. HK$1.61 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.